Filing Flows › Comparisons › PSNL vs BDSX
Personalis vs Biodesix: PSNL and BDSX compared
Personalis is the larger company: $25.6M of revenue in its latest quarter (Q3 2026) against $24.0M for Biodesix (Q3 2026). Personalis is growing faster (+77% against +10% a year earlier). Biodesix is more profitable, with an operating margin of -25.4% against -138.8%.
Where the money goes: PSNL and BDSX
Personalis (PSNL) · Q3 2026
Personalis, Q3 2026: revenue $25.6M (+77% year over year), operating margin -138.8%, net loss $33.8M, operating cash flow −$27.1M. The chart follows the revenue to costs, profit and cash.
Biodesix (BDSX) · Q3 2026
Biodesix, Q3 2026: revenue $24.0M (+10% year over year), operating margin -25.4%, net loss $8.0M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
| Personalis (PSNL) | Biodesix (BDSX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $25.6M | $24.0M |
| Revenue growth, Y/Y | +77% | +10% |
| Operating margin | -138.8% | -25.4% |
| Net earnings | −$33.8M | −$8.0M |
| Net margin | -132.1% | -33.4% |
| Operating cash flow | −$27.1M | −$7.2M |
Where the revenue comes from
Biodesix
- Diagnostic Tests: $23.1M (96%)
- Development Services: $986K (4%)
Questions
Which is bigger, Personalis or Biodesix?
Personalis is the larger company: $25.6M of revenue in its latest quarter (Q3 2026) against $24.0M for Biodesix (Q3 2026).
Is Personalis or Biodesix growing faster?
Personalis is growing faster (+77% against +10% a year earlier).
Which is more profitable, Personalis or Biodesix?
Biodesix is more profitable, with an operating margin of -25.4% against -138.8%.
More: Personalis earnings · how Personalis makes money · Biodesix earnings · how Biodesix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.